Biolux Research Holdings, Inc.
8
0
0
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 55/100
25.0%
2 terminated/withdrawn out of 8 trials
66.7%
-19.8% vs industry average
0%
0 trials in Phase 3/4
100%
4 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
OrthoPulse Gen 2 Initial Device Evaluation and Assessment of Clinical Effectiveness (CA)
Role: lead
OrthoPulse 2.0 and 2.1 Feasibility Evaluation
Role: lead
The Effect of OrthoPulse™ on the Rate of Orthodontic Tooth Movement
Role: lead
The Effect of OrthoPulse Photobiomodulation on the Rate of Tooth Movement During Alignment With Fixed Appliances
Role: lead
The Effect of OrthoPulse™ Photobiomodulation on Tooth Movement and Treatment Time When Used With Invisalign Treatment
Role: lead
Effect of Intra-Oral Photobiomodulation on Orthodontic Treatment Time
Role: lead
The Effects of Extraoral Photobiomodulation on the Rate of Orthodontic Alignment
Role: lead
OrthoPulse™ and Its Effect on the Rate of Orthodontic Tooth Alignment: A Pilot Feasibility Study
Role: lead
All 8 trials loaded